Suture Repair vs Mesh Repair for Incisional Hernia
Launched by CLAYTON PETRO · Oct 26, 2022
Trial Information
Current as of July 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is exploring two different methods for repairing incisional hernias, which are bulges that can occur through a scar in the abdominal wall. Researchers want to find out if using stitches alone (suture repair) is just as good as using a mesh material for the repair in terms of patients' quality of life one year after surgery. The trial focuses on patients with hernias that are between 2 and 6 centimeters wide and aims to determine if there are any significant differences in how patients feel after their procedure.
To participate in this trial, you need to be an adult over 18 years old, have an incisional hernia between 2 and 6 centimeters wide, and be in good general health (classified as CDC class I). However, people with certain conditions, such as those needing emergency surgery or those who have had previous hernia repairs with mesh at the same site, are not eligible. If you join, you can expect to be randomly assigned to either the stitch repair or mesh repair group and will be followed up a year later to see how you’re doing. This study is currently recruiting participants, and your involvement could help improve future hernia repair techniques.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults \>18 years old.
- • Anticipated hernia defect 2-6cm in width
- • Non-emergent case
- • CDC class I
- • Patients who previously underwent primary ventral hernia repair without the use of mesh
- • Incisional hernia
- Exclusion Criteria:
- • Emergent cases
- • Patients \< 18 years old
- • Patients who are pregnant
- • Patients who previously underwent a prior ventral hernia repair with mesh at the site of the intended repair. Abdominal mesh in separate locations would be allowed.
- • Ventral hernia \<2cm or \> 6 cm in width
- • Primary hernia
- • CDC wound class II-IV
About Clayton Petro
Clayton Petro is a leading clinical trial sponsor dedicated to advancing medical research and innovation through the development of novel therapies. With a strong focus on improving patient outcomes, Clayton Petro collaborates with healthcare professionals, regulatory bodies, and research institutions to design and execute high-quality clinical trials across various therapeutic areas. Their commitment to ethical practices and rigorous scientific standards ensures the integrity of their research, while their experienced team of professionals works diligently to bring groundbreaking treatments to market, ultimately enhancing the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Gainesville, Florida, United States
Gainesville, Florida, United States
Columbus, Ohio, United States
Cleveland, Ohio, United States
Patients applied
Trial Officials
Clayton Petro, MD
Principal Investigator
The Cleveland Clinic
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials